What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 4, 2012, Pages 322-327

  Pengo, Vittorio ^a   Banzato, Alessandra ^a   Bison, Elisa ^a   Bracco, Alessia ^a   Denas, Gentian ^a   Ruffatti, Amelia ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

antiphospholipid antibodies; glycoprotein I; lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; GLYCOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; PLACEBO; PROTHROMBIN ANTIBODY;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CLOTTING TEST; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FOLLOW UP; HETEROZYGOTE; HUMAN; LABORATORY TEST; PLACENTA DISORDER; PREGNANCY; PRIORITY JOURNAL; PROTEIN DOMAIN; RADIOIMMUNOASSAY; RECURRENT DISEASE; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84861341979     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1304719     Document Type: Article

References (52)

1. Harris EN, Gharavi AE, Hughes GRV. Anti-phospholipid antibodies. Clin Rheum Dis: 1985; 11 3 591 609 (Pubitemid 16238189)
2. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis: 1987; 46 1 1 6 (Pubitemid 17225122)
3. Fiumara NJ. Biologic false-positive reaction for syphilis: Massachusetts, 1954-1961. N Engl J Med: 1963; 268 402 405
4. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb: 1972; 1 75 95
5. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest: 1980; 66 3 397 405 (Pubitemid 10053902)
6. Asherson RA, Harris EN. Anticardiolipin antibodiesclinical associations. Postgrad Med J: 1986; 62 734 1081 1087
7. Hughes GR. The anticardiolipin syndrome. Clin Exp Rheumatol: 1985; 3 4 285 286 (Pubitemid 16209618)
8. Harris EN, Asherson RA, Hughes GRV. Antiphospholipid antibodiesautoantibodies with a difference. Annu Rev Med: 1988; 39 261 271
9. Wilson WA, Gharavi AE, Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum: 1999; 42 7 1309 1311 (Pubitemid 30265586)
10. Miyakis S, Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
11. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost: 2005; 93 6 1147 1152 (Pubitemid 40823521)
12. Ruffatti A, Olivieri S, Tonello M., et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost: 2008; 6 10 1693 1696
13. Shamonki JM, Salmon JE, Hyjek E, Baergen RN. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol: 2007; 196 2 167, e1-e5
14. Erkan D, Lockshin MD. What is antiphospholipid syndrome? Curr Rheumatol Rep: 2004; 6 6 451 457
15. Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A.; Italian Federation of Anticoagulation Clinics (FCSA). Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Thromb Res: 2007; 120 1 127 133 (Pubitemid 46628706)
16. Harris EN, Gharavi AE, Hughes GR. Anticardiolipin antibody testing: the need for standardization. Arthritis Rheum: 1987; 30 7 835 837
17. Rampazzo P, Biasiolo A, Garin J., et al. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins. Thromb Haemost: 2001; 85 1 57 62 (Pubitemid 32050943)
18. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A: 1990; 87 11 4120 4124
19. Galli M, Comfurius P, Maassen C., et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet: 1990; 335 8705 1544 1547 (Pubitemid 20189625)
20. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet: 1990; 336 8708 177 178 (Pubitemid 20225005)
21. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med: 1994; 179 2 457 462 (Pubitemid 24058733)
22. Roubey RA, Eisenberg RA, Harper MF, Winfield JB. " Anticardiolipino" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol: 1995; 154 2 954 960
23. Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface. Thromb Haemost: 1995; 73 1 29 34
24. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol: 2009; 8 11 998 1005
25. de Laat B, Pengo V, Pabinger I., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost: 2009; 7 11 1767 1773
26. Pengo V, Biasiolo A, Gresele P., et al. Participating Centres of Italian Federation of Thrombosis Centres (FCSA). Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost: 2007; 5 5 925 930 (Pubitemid 46691720)
27. Pengo V, Biasiolo A, Gresele P., et al. A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. Arterioscler Thromb Vasc Biol: 2007; 27 12 e309 e310
28. de Groot PG, Lutters B, Derksen RH, Lisman T, Meijers JC, Rosendaal FR. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost: 2005; 3 9 1993 1997 (Pubitemid 43086056)
29. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood: 2003; 101 5 1827 1832 (Pubitemid 36237580)
30. de Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood: 2005; 105 4 1540 1545 (Pubitemid 40223671)
31. Simmelink MJ, Derksen RH, Arnout J, De Groot PG. A simple method to discriminate between beta2-glycoprotein I- and prothrombin-dependent lupus anticoagulants. J Thromb Haemost: 2003; 1 4 740 747
32. Pengo V, Biasiolo A, Pegoraro C, Iliceto S. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants. J Thromb Haemost: 2004; 2 5 702 707 (Pubitemid 40185707)
33. Garca CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol: 1997; 37 1 118 124 (Pubitemid 27075976)
34. Ruffatti A, Tonello M, Del Ross T., et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost: 2006; 96 3 337 341 (Pubitemid 44377818)
35. Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost: 1997; 77 1 123 126 (Pubitemid 27064980)
36. Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood: 2003; 102 8 2717 2723 (Pubitemid 37248837)
37. Sailer T, Zoghlami C, Kurz C., et al. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost: 2006; 95 5 796 801
38. Zoghlami-Rintelen C, Vormittag R, Sailer T., et al. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost: 2005; 3 6 1160 1165 (Pubitemid 41725235)
39. Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res: 2009; 123 3 482 487
40. Lee EY, Lee CK, Lee TH., et al. Does the anti-2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res: 2003; 111 1-2 29 32 (Pubitemid 37485922)
41. Male C, Foulon D, Hoogendoorn H., et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood: 2005; 106 13 4152 4158 (Pubitemid 41775921)
42. Forastiero R, Martinuzzo M, Pombo G., et al. A prospective study of antibodies to 2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost: 2005; 3 6 1231 1238 (Pubitemid 41725247)
43. Galli M. The antiphospholipid triangle. J Thromb Haemost: 2010; 8 2 234 236
44. Ruffatti A, Del Ross T, Ciprian M., et al. Antiphospholipid Syndrome Study Group of Italian Society of Rheumatology. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis: 2011; 70 6 1083 1086
45. Pengo V, Ruffatti A, Legnani C., et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood: 2011; 118 17 4714 4718
46. Roger VL, Go AS, Lloyd-Jones DM., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics2011 update: a report from the American Heart Association. Circulation: 2011; 123 4 e18 e209
47. Erkan D, Harrison MJ, Levy R., et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum: 2007; 56 7 2382 2391 (Pubitemid 47173586)
48. Hereng T, Lambert M, Hachulla E., et al. Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus: 2008; 17 1 11 15 (Pubitemid 351487013)
49. Girn-Gonzlez JA, Garca del Ro E, Rodrguez C, Rodrguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol: 2004; 31 8 1560 1567 (Pubitemid 39006638)
50. Girn-Gonzlez JA, Garca del Ro E, Rodrguez C, Rodrguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol: 2004; 31 8 1560 1567 (Pubitemid 39006638)
51. Galli M, Borrelli G, Jacobsen EM., et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood: 2007; 110 4 1178 1183 (Pubitemid 47281414)
52. Pengo V. A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome. J Thromb Haemost: 2008; 6 6 1048 1049 (Pubitemid 351689934)